Improved ex vivo fluorescence imaging of human head and neck cancer using the peptide tracer TPP-IRDye800 targeting membrane-bound Hsp70 on tumor cells

期刊论文
出版模式：

开放获取
发表日期：

2024年10月15日

查看全文

Katharina L. K. Holzmann,
Johanna L. Wolf,
Stefan Stangl,
Philipp Lennartz,
Atsuko Kasajima,
Carolin Mogler,
Bernhard Haller,
Eva-Vanessa Ebert,
Daniel Jira,
Maren L. A. Lauterbach,
Franziska von Meyer,
Leonhard Stark,
Leonie Mauch,
Benedikt Schmidl,
Barbara Wollenberg,
Gabriele Multhoff,
Markus Wirth

摘要

Background

The primary goal of surgery in HNSCC is the complete resection of tumor cells with maximum preservation of normal tissue. The membrane Hsp70-targeting fluorescence labelled peptide TPP-IRDye800 represents a promising tool for real-time intraoperative tumor visualization, enabling the detection of true tumor margins, critical isles of high-grade dysplasia and LN metastases.

Methods

Membrane Hsp70 (mHsp70) expression on HNSCC cell lines and primary HNSCC was determined by flow cytometry and fluorescence microscopy using FITC-conjugated mAb cmHsp70.1 and TPP. TPP-IRDye800 was sprayed on freshly resected tumor material of immunohistochemically confirmed HNSCC and LN metastases for tumor imaging. TBRs were compared using TPP-IRDye800 and Cetuximab-IRDye680, recognizing EGFR.

Results

mHsp70 expressing HNSCC cells specifically bind and internalize TPP in vitro. The TBR (2.56 ± 0.39) and AUC [0.98 CI, 0.95–1.00 vs. 0.91 CI, 0.85–0.97] of TPP-IRDye800 on primary HNSCC was significantly higher than Cetuximab-IRDye680 (1.61 ± 0.39) (p = 0.0068) and TPP-IRDye800 provided a superior tumor delineation. Fluorescence imaging showed higher AUC values than a visual inspection by surgeons [0.97 CI, 0.94–1.00 vs. 0.92 CI, 0.88–0.97] (p = 0.048). LN metastases could be visualized using TPP-IRDye800. Real-time tissue delineation was confirmed using the clinically applied KARL-STORZ imaging system.

Conclusion

TPP-IRDye800 is a promising fluorescence imaging probe for HNSCC.